YQD-31805-12088

2 vaccinations 15 coded responses 16 check-ins 15 free-text entries 1 call case

Sex: Female
Age at first dose: 51-55
ZIP prefix: 342 / FL
Registered: 2021-04-28

Relationship: Self
Race: White
Ethnicity: Not Hispanic or Latino

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-04-06
Dose 1 — Pfizer-BioNTech
2021-04-28
Registered in v-safe
2021-04-28
Survey response — day 21, dose 1
MedDRA: Headache, Lymphadenopathy, Nausea, Vomiting — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Swollen lymph nodes in both armpits and groin, nausea, vomiting and headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-03
Dose 2 — Pfizer-BioNTech
2021-05-04
Survey response — days 1–6 daily, dose 2
MedDRA: Hyperhidrosis — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Sweating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-05
Survey response — days 1–6 daily, dose 2
MedDRA: Hyperhidrosis — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Sweating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-06
Survey response — days 1–6 daily, dose 2
MedDRA: Hyperhidrosis, Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Fever · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Sweating. Swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-07
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-08
Survey response — days 1–6 daily, dose 2
MedDRA: Lymphadenopathy — Feeling: Fair · Site: Pain, Swelling · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-09
Survey response — days 1–6 daily, dose 2
MedDRA: Hyperhidrosis, Lymphadenopathy — Feeling: Fair · Site: Pain · Chills, Headache, Joint pains, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities

Free text: Sweating and swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-10
Survey response — day 7, dose 2
MedDRA: Hyperhidrosis, Lymphadenopathy — Feeling: Fair · Site: Pain · Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work, Be unable to do your normal daily activities

Free text: Sweating and swollen lymph nodes

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-17
Survey response — day 14, dose 2
MedDRA: Hyperhidrosis, Lymphadenopathy — Feeling: Fair · Be unable to do your normal daily activities

Free text: Swollen lymph nodes and sweating

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-24
Survey response — day 21, dose 2
MedDRA: Brain fog, Fatigue, Headache, Nausea — Feeling: Poor · Be unable to work, Be unable to do your normal daily activities

Free text: Severe fatigue, brain fog, nausea and headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-05-31
Health check-in — day 28, dose 2
Feeling: Fair

Adult check-in
2021-06-07
Survey response — day 35, dose 2
MedDRA: Brain fog, Hyperhidrosis, Memory impairment — Feeling: Fair · Be unable to do your normal daily activities

Free text: Foggy brain, sweating and forgetfulness

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-06-14
Survey response — day 42, dose 2
MedDRA: Brain fog, Hyperhidrosis — Feeling: Fair · Be unable to do your normal daily activities

Free text: Excessive sweating and brain fog

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-08-02
Survey response — 3 months, dose 2
MedDRA: Fatigue, Memory impairment — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities

Free text: Tiredness, forgetfulness

MedDRA releases: 2021-09,2024-11 · check-in free text available
2021-11-02
Survey response — 6 months, dose 2
MedDRA: Abnormal dreams, Hyperhidrosis — Feeling: Fair · Be unable to do your normal daily activities

Free text: Excessive sweat and extremely weird dreams

MedDRA releases: 2024-11 · check-in free text available
2022-05-03
Survey response — 12 months, dose 2
MedDRA: Brain fog, Dyspnoea, Fatigue — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit

Free text: Fatigue, shortness of breath, foggy

MedDRA releases: 2024-11 · check-in free text available
2022-05-03
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Outpatient clinic or urgent care clinic visit · 1 call case(s)
2022-05-04
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-04-06	Pfizer-BioNTech
2	2021-05-03	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-05-03	Unsuccessful

Free text

Release 8 — day 21, dose 1

2021-04-28

Symptoms: Swollen lymph nodes in both armpits and groin, nausea, vomiting and headache

Release 8 — days 1–6 daily, dose 2

2021-05-04

Systemic reaction (other): Sweating

2021-05-05

Systemic reaction (other): Sweating

2021-05-06

Systemic reaction (other): Sweating. Swollen lymph nodes

2021-05-07

Systemic reaction (other): Swollen lymph nodes

2021-05-08

Systemic reaction (other): Swollen lymph nodes

2021-05-09

Systemic reaction (other): Sweating and swollen lymph nodes

Release 8 — day 7, dose 2

2021-05-10

Systemic reaction (other): Sweating and swollen lymph nodes

Release 8 — day 14, dose 2

2021-05-17

Symptoms: Swollen lymph nodes and sweating

Release 8 — day 21, dose 2

2021-05-24

Symptoms: Severe fatigue, brain fog, nausea and headache

Release 8 — day 35, dose 2

2021-06-07

Symptoms: Foggy brain, sweating and forgetfulness

Release 9 — day 42, dose 2

2021-06-14

Symptoms: Excessive sweating and brain fog

Release 9 — 3 months, dose 2

2021-08-02

Symptoms: Tiredness, forgetfulness

Release 10 — 6 months, dose 2

2021-11-02

Symptoms: Excessive sweat and extremely weird dreams

Release 11 — 12 months, dose 2

2022-05-03

Symptoms: Fatigue, shortness of breath, foggy

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Abnormal dreams	·	·	✓
SD	Brain fog	✓	✓	✓
SD	Dyspnoea	·	·	✓
SD	Fatigue	✓	✓	✓
SD	Headache	✓	✓	✓
SD	Hyperhidrosis	✓	✓	✓
SD	Lymphadenopathy	✓	✓	✓
SD	Memory impairment	✓	✓	✓
SD	Nausea	✓	✓	✓
SD	Vomiting	✓	✓	✓
SRO	Hyperhidrosis	✓	✓	✓
SRO	Lymphadenopathy	✓	✓	✓

✓ active code · ○ coded but marked inactive · blank = not in that release